Table 2.

Delivery routes of the selected polysaccharide-based DDSs.

Delivery Route	Polysaccharide	Formulation	Active Agent	Reference
oral	ALG	films	posaconazole	[24]
	ALG	micelles	murcumin	[27]
	ALG	nanogels	gadolinium	[40]
	CS	nanoparticles	cisplatin	[67]
	CS	nanoparticles	doxorubicin	[98]
	CS	microspheres	polyphenon-60	[102]
	HA	nanocapsules	garlic oil	[122]
	PC	milibeads	mesalazine	[128]
	ST	films	doxorubicin	[144]
	CL, ALG	hydrogel	hesperidin	[150]
	CS, PC	films	clotrimazole	[162]
	CS, HA	nanocapsules	oleic acid	[121]
	CS, ALG	microspheres	omega-3 oil	[180]
ocular	HA	drops	choline salicylate	[112]
nasal	ALG, PC	powder	dexamethasone	[161]
vaginal/anal	CS	powder	Chelidonii H.	[65]
	CS	microparticles	Zidovudine	[74]
	CS	tablets	fluconazole	[75]
transdermal	ALG	hydrogel	cymaroside	[21]
	ALG	membrane	gentamicin	[22]
	ALG	nanocapsules	ebselen	[38]
	CS	powder	clotrimazole	[58]
	CS	hydrogel	Calendulae flos	[77]
	CS	nanoparticles	cannabidiol	[96]
	CS	nanorods	azelaic acid	[97]
	CS	hydrogel	genistein	[107]
	CL, ALG, CS	microparticles	dexamethasone	[151]
	CL, ALG	hydrogel	2-phenoxyethanol	[154]
	CS, HA	films	gentamicin	[168]
pulmonary	DX	powder	cromoglycate	[183]
parenteral	PC	hydrogel	bioactive glass	[130]
	CS, HA	hydrogel	genipin	[167]